Highmark Covers AppliedVR’s Product for Chronic Low Back Pain
More than 4 million Highmark commercial members now have access to AppliedVR's RelieVRx as a covered therapeutic.
More than 4 million Highmark commercial members now have access to AppliedVR's RelieVRx as a covered therapeutic.
AppliedVR released study results demonstrating VR’s ability to help patients suffering from chronic low back pain. The technology was able to increase participants' brain coherence and help them achieve a slower breathing rate — two metrics associated with reduced pain.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
AppliedVR teamed up with the National Cancer Institute to study the feasibility of VR to alleviate anxiety in brain tumor patients undergoing imaging scans. The research partners recently announced interim analysis results from their clinical study — they said that not only would VR intervention be a feasible option to reduce patients’ anxiety, but that patients would report high satisfaction levels as well.
CMS recently established a unique code for AppliedVR’s flagship product, marking the first time a digital therapeutic or immersive therapeutic has ever been placed in an existing benefit category. The eight-week program is a physician-prescribed solution that allows patients to manage their chronic lower back pain without opioids from the comfort of their own home.
Experts think virtual reality (VR) can help address the country's rising levels of pain and anxiety. By flooding the brain with positive signals, VR experiences can act as a drug-free alternative to pain and mental health management — and hospitals across the nation are deploying the technology.
The Food and Drug Administration granted the company de novo clearance for its VR programs to help reduce chronic lower back pain. AppliedVR’s eight-week program is based on cognitive behavioral therapy.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
The startup is working with Curebase to launch five clinical trials to test its VR-based therapeutic for chronic pain. They plan to enroll a total of more than 2,000 people.
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last year to use its VR platform to treat fibromyalgia and lower back pain.
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
Digital health startup AppliedVR shared results from a pivotal study of its platform for lower back pain relief. The company plans to submit the results to the FDA in the next year.
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of a 92-person virtual trial testing VR for pain management at home.
Virtual reality has evolved from being a technological novelty to a legitimate clinical tool in areas like chronic pain management and neurological rehab, leading experts to think through how best to integrate VR into healthcare.
During a panel discussion at the Connected Health Conference in Boston, two physicians and a patient touched on how virtual reality is aiding a variety of healthcare consumers. Yet as one panelist noted, we shouldn't overpromise what it can do.
In cancer care, virtual reality could be enlisted to improve patient therapy and physician education with minimal cost to hospital systems.